Valuation: SMAIO

Market Cap 43.93M 50M 41.01M 37.64M 70.45M 4.79B 72.19M 486M 190M 2.37B 188M 184M 8.19B P/E 2026 *
-20x
P/E 2027 * 195x
Enterprise Value 42.43M 48.29M 39.61M 36.35M 68.05M 4.63B 69.72M 470M 184M 2.29B 181M 177M 7.91B EV / Sales 2026 *
3.86x
EV / Sales 2027 * 2.69x
Free-Float
29.17%
Yield 2026 *
-
Yield 2027 * -
1 day+0.77%
1 week-4.15%
Current month+1.29%
1 month+1.29%
3 months+6.22%
6 months+12.29%
Current year+25.76%
1 week 7.3
Extreme 7.3
8.4
1 month 7.3
Extreme 7.3
8.94
Current year 6
Extreme 6
9.1
1 year 5.5
Extreme 5.5
9.1
3 years 2.14
Extreme 2.14
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.77%-4.15%+3.42%+222.13% 50M
-0.87%+4.04%+58.60%+163.92% 1,079B
-0.45%+3.87%+57.95%+52.18% 640B
+0.04%+3.95%+37.69%+74.54% 465B
-1.99%+1.46%+36.59%+31.04% 353B
-1.56%+0.03%+34.39%+40.22% 301B
-2.37%+0.98%+11.43%+14.54% 271B
-1.68%+3.62%+2.12%-39.22% 228B
-1.39%+5.90%+27.70%+64.00% 209B
-1.18%+1.83%+16.20%+72.69% 165B
Average -1.12%+4.35%+28.61%+69.60% 370.97B
Weighted average by Cap. -1.33%+4.86%+41.28%+77.73%

Financials

2026 *2027 *
Net sales 11M 12.52M 10.27M 9.42M 17.64M 1.2B 18.07M 122M 47.62M 593M 47M 45.98M 2.05B 16M 18.21M 14.93M 13.71M 25.66M 1.74B 26.29M 177M 69.26M 863M 68.36M 66.88M 2.98B
Net income -2.25M -2.56M -2.1M -1.93M -3.61M -245M -3.7M -24.9M -9.74M -121M -9.61M -9.41M -420M 250K 285K 233K 214K 401K 27.25M 411K 2.77M 1.08M 13.49M 1.07M 1.05M 46.62M
Net Debt -1.5M -1.71M -1.4M -1.28M -2.41M -164M -2.46M -16.6M -6.49M -80.91M -6.41M -6.27M -280M -900K -1.02M -840K -771K -1.44M -98.11M -1.48M -9.96M -3.9M -48.55M -3.85M -3.76M -168M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
30/07/26 EUR 7.860 +0.77% 507
29/07/26 EUR 7.800 -2.50% 2,563
28/07/26 EUR 8.000 -1.23% 295
27/07/26 EUR 8.100 -2.41% 147
24/07/26 EUR 8.300 +1.22% 312
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.800EUR
Average target price
8.200EUR
Spread / Average Target
+5.13%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock